Healthtech funding in Q2 2012

European Healthtech startup funding raised during Q2 2012.

In Q2 2012, 19 European Healthtech companies closed 19 funding rounds and raised €137M in equity funding (excluding debt and grants), up 14.5% versus Q2 2011. Netherlands led by capital raised, and 83North was the most active investor. Data as of 6 Nov 2026.

Equity funding

€137M

+14.5% vs Q2 2011 · excl. debt & grants

Funding rounds

-17.4% vs Q2 2011

Companies

Top country

Netherlands

Rank among sectors

10.0% of sector funding

Top-10 round share

96.2%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Apr	€3.7M	3
May	€119M	11
Jun	€14M	5

Top countries

by € raised

Data table

	Healthtech — top countries by capital, Q2 2012
Netherlands	€49M
UK	€41M
Israel	€12M
Denmark	€11M
Sweden	€7.8M
Switzerland	€7.0M
France	€3.3M
Finland	€2.7M

Stage mix

by € raised

Data table

	Healthtech — stage mix, Q2 2012
Series D+	€57M
Growth/Late	€39M
Series B	€14M
Early VC	€12M
Seed	€7.0M
Series A	€4.5M
Series C	€3.7M

Top deals

largest disclosed rounds in Q2 2012

Company	Stage	Date	Amount
Agendia	Series D+	May 2012	€49M
Oxford Nanopore Technologies	Growth/Late	May 2012	€39M
Egalet	Series B	May 2012	€11M
BONESUPPORT	Early VC	Jun 2012	€7.8M
Gamida Cell	Series D+	May 2012	€7.6M
Simplee	Series A	May 2012	€4.5M
Spinelab	Series C	May 2012	€3.7M
Alize Pharma	Seed	Jun 2012	€3.3M
Aleva Neurotherapeutics	Series B	Apr 2012	€3.3M
Arctic Diagnostics	Early VC	May 2012	€2.7M
Inbiomotion	Seed	Jun 2012	€2.1M
Sedicidodici	Seed	May 2012	€900k
DrEd Online Doctor	Seed	Jun 2012	€719k
CamStent	Early VC	May 2012	€615k
Alchemy Pharmatech	Early VC	Jun 2012	€500k

View all 19 Healthtech deals in Q2 2012 →

Top investors

most active in Q2 2012, by deal count

← All 2012 Healthtech funding